ORAMED PHARMACEUTICALS INC. (ORMP)

SEC filing

ORAMED PHARMACEUTICALS INC.

ORMP · CIK 1176309

4 · Sep 25, 2026 · Director, Chief Scientific Officer Kidron Miriam was granted 417.42K shares; reported 493.00K Stock option (right to buy)

Director, Chief Scientific Officer Kidron Miriam was granted 417.42K shares; reported 493.00K Stock option (right to buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.